Weight Loss & Cardiovascular Health: Exercise, Diet & Modern Tirzepatide Therapy

Author: Dr. Mohammad Esmail Aramesh Boroujeni Published Date: Aug 12, 2026 پیشگیری و سلامت ۲۱ views

Impact of weight reduction on heart function, safe exercise guidelines, and Tirzepatide (dual GLP-1/GIP) breakthrough therapy.

Excess visceral weight significantly increases cardiac workload and accelerates coronary atherosclerosis. Losing just 5-10% of body weight improves blood pressure, lipid profile, and glycemic control.

Core Weight Management Principles:

Regular Aerobic Exercise: At least 150 minutes per week of brisk walking or moderate cycling.
Nutritional Restructuring: Replacing refined carbs and trans fats with nutrient-dense foods.

Modern Pharmacotherapy: Tirzepatide (Mounjaro / Zepbound)

Tirzepatide is a novel dual GLP-1 and GIP receptor agonist that has revolutionized obesity management. It significantly reduces appetite, enhances insulin sensitivity, and promotes substantial weight reduction, improving overall cardiovascular health when prescribed under medical supervision.

محاسبه‌گر BMI و ارزیاب آمادگی داروی تیرزپاتاید (Tirzepatide)

بررسی شاخص توده بدنی و اثر کاهش وزن بر فشار خون و سلامت قلب

محاسبه‌گر لاغری

قد (سانتی‌متر): 175 cm وزن فعلی (کیلوگرم): 95 kg

شاخص توده بدنی (BMI): 31.0

چاقی درجه ۱ (Obesity Class I)

با کاهش ۱۰ درصد از وزن بدن (۹.۵ کیلوگرم)، فشار خون سیستولیک شما حدود ۱۰ میلی‌متر جیوه کاهش یافته و کاندیدای ارزیابی داروی تیرزپاتاید هستید.

Key Takeaways & Step-by-Step Instructions

Every kilogram of weight loss can lower systolic blood pressure by approximately 1 mmHg, reducing cardiac workload.

Brisk walking on flat terrain is ideal. Heavy isometric resistance exercise without medical clearance should be avoided.

Tirzepatide mimics native incretin hormones, enhancing satiety, delaying gastric emptying, and optimizing lipid metabolism.

Comprehensive cardiac evaluation at Dr. Aramesh clinic ensures safety before initiating GLP-1/GIP therapy.

Dr. Mohammad Esmail Aramesh Boroujeni

Cardiologist & Cardiovascular Specialist (Board Certified)

Born in Boroujen, MD from Shahrekord University of Medical Sciences and Cardiology Residency from Isfahan University of Medical Sciences. Board certified in Cardiovascular Diseases. Patient-centered clinician dedicated to daily medical literature updates and attentive listening to patient concerns.